Google
AARD — AARDVARK THERAPEUTICS, INC. COMMON STOCK (Healthcare >> Biotechnology)
AARD FAQ
What is AARD's ROE?
AARDVARK THERAPEUTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -80.32%.
What is AARD's dividend yield?
AARDVARK THERAPEUTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is AARD's Deepscope Quality Score?
Deepscope rates AARD's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AARD?
Deepscope's AI Timing Score for AARD is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AARD belong to?
AARDVARK THERAPEUTICS, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.68
Price
-0.26
(-6.60%)
Day Change
|
|
|---|
AARD, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 90 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.68 |
| PBV / Sector |
0.96 / 4.63
GREAT
|
| Earning Per Share | -3.09 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.87 M
GREAT
|
| Average 1W Daily Value |
0.53 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:25 |
| Symbol | AARD |
| Name | AARDVARK THERAPEUTICS, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 21.82 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 83.12 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4370 La Jolla Village Drive, San Diego, CA, United States, 92122
Phone: 858 225 7696
Website: https://aardvarktherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
